Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.4860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement
Via ACCESSWIRE
Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders
Via ACCESSWIRE
Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022
Via ACCESSWIRE
Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech
Via ACCESSWIRE
Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp
Via ACCESSWIRE
Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense
Via ACCESSWIRE
Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company
Via ACCESSWIRE
Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.
Via ACCESSWIRE
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
Via ACCESSWIRE
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories
Via ACCESSWIRE
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Regains Nasdaq Minimum Bid Price Compliance
Via ACCESSWIRE
Cosmos Health CEO Participated in the Last Fundraising of the Company
Via ACCESSWIRE
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests
Via ACCESSWIRE
BioMedNewsBreaks – Cosmos Health Inc. (NASDAQ: COSM) Begins Process for Upstream Dual Listing
Via Investor Brand Network
Cosmos Health Announces Application for Dual Listing on Upstream
Via ACCESSWIRE
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
Via ACCESSWIRE
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
Via ACCESSWIRE
Cosmos Health Announces Stock Buyback Program
Via ACCESSWIRE
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
Via ACCESSWIRE
Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
Via ACCESSWIRE
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split
Via ACCESSWIRE
Cosmos Health Retains Shareholder Intelligence Services, LLC
Via ACCESSWIRE
MarketBeat: Week in Review 11/28 – 12/02
Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week 
Via MarketBeat
Topics Cannabis Economy Stocks
Exposures COVID-19 Cannabis Economy
Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company
Via ACCESSWIRE
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management
Via ACCESSWIRE
Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.